Disclaimer: This article is educational and is not medical advice
Li M, Zhao S, Wu S, Yang X, Feng H
Semaglutide (Ozempic, Wegovy) has a half-life of approximately 7 days, requiring approximately 5 weeks for 97% clearance from the body after the final injection
Published clinical trial data generally shows higher average weight loss with brand-name tirzepatide than with brand-name semaglutide in controlled conditions - approximately 20.9% body weight reduction with tirzepatide in the SURMOUNT-1 trial versus approximately 14.9% with semaglutide in the STEP-1 trial
Based on what your doctor recommends and how you progress, you could should consider taking blood tests roughly every 3 months to monitor progress in key blood biomarkers and how they are improving
While its still new, scientists are excited about its potential, as it has shown significant results in treating obesity